| 英文别名 |
Vitexin;ORIENTOSIDE;APIGENIN-8-C-GLUCOSIDE;8-beta-d-glucopyranosyl-apigenin;8-d-glucosyl-4’,5,7-trihydroxy-flavon;8-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;4H-1-Benzopyran-4-one,8-b-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-;Apigenin8-C-glucoside;4',5,7-trihydroxyflavone-8-C-glucoside;8-Glucosylapigenin;Vitxein;5,7-Dihydroxy-8-beta-D-glucopyranosyl-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;5,7-Dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one;5,7-Dihydroxy-2-(4-hydroxyphenyl)-8-[(2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ch;5,7-Dihydroxy-2-(4-hydroxyphenyl)-8-[(2R,3S,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one;A823380;APIGENIN-8-C-.BETA.-D-GLUCOPYRANOSIDE;C01460;Vitexin 100 microg/mL in Acetone:Water;Vitexin,(S);FLAVONE, 8-.BETA.-D-GLUCOPYRANOSYL-4',5,7-TRIHYDROXY-;CS-0007090;FLAVONE, 8-beta-D-GLUCOPYRANOSYL-4',5,7-TRIHYDROXY-;4H-1-Benzopyran-4-one, 8-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-;Apigenin-8-C-glucoside;4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-.beta.-D-glucopyranosyl-2-(4-hydroxyphenyl)-;EINECS 222-963-8;Q259075;8-beta-D-Glucopyranosyl-apigenin;VITEXINE;HY-N0013;VITEXIN [WHO-DD];VITEXIN [USP-RS];UNII-9VP70K75OK;5,7,4'-Trihydroxyflavone 8-C-.beta.-D-glucopyranoside;VITEXIN (CONSTITUENT OF HAWTHORN LEAF WITH FLOWER);(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-;Flavone, 8-D-glucosyl-4',5,7-trihydroxy-;Vitexin, analytical standard;SGEWCQFRYRRZDC-VPRICQMDSA-N;5,7-dihydroxy-2-(4-hydroxyphenyl)-8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-4H-chromen-4-one;(1S)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol;5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one;4H-1-Benzopyran-4-one, 8-.beta.-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-;8-glycosylapigenin;s9192;4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-beta-D-glucopyranosyl-2-(4-hydroxyphenyl)-;HB4123;Apigenin 8-C-glucoside;Q-100437;SCHEMBL25277;AC-6086;AS-55909;VITEXIN (USP-RS);CHEBI:16954;8C-hexosyl apigenin;Vitexin, primary pharmaceutical reference standard;8-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;DTXCID00112778;(1S)-1,5-anhydro-1-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl)-D-glucitol;VITEXINA;Vitexin, United States Pharmacopeia (USP) Reference Standard;1ST158047;NS00018314;BDBM50362886;CHEMBL487417;AKOS025311479;5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one;9VP70K75OK;MFCD00017456;DTXSID90190287;CCG-208516;8-glycosyl-apigenin;VITEXIN [INCI];NCGC00163642-01;3681-93-4;8-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-;Apigenin 8-C-.beta.-D-glucoside;Holy Berry Extract |